Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

FDA approves once-monthly Sublocade to treat opioid use disorder

Dec. 1, 2017

FDA accepts, grants priority review to lofexidine NDA

Nov. 22, 2017

Orexo's Zubsolv approved for opioid dependence in Europe

Nov. 21, 2017

OX1 receptor antagonist C4X_3256 demonstrates efficacy in nicotine dependence rat model

Nov. 15, 2017

FDA committee recommends approval of Braeburn Pharmaceuticals' CAM-2038 for opioid use disorder

Nov. 2, 2017

FDA awards orphan drug status to Pluristem's PLX-R18 for ARS

Oct. 20, 2017

Otsuka submits NDA for nalmefene in Japan

Oct. 19, 2017

Anti-ALDH2 gene therapy could discourage alcohol intake

Oct. 11, 2017

NIH grant supports exploration of NVP-015 for use against chemical threats

Oct. 5, 2017

Emergent BioSolutions completes acquisition of raxibacumab from GSK

Oct. 4, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...